Thanks Rocky. Sounds like an efficacy possibility to me.
The stock is acting quite well.
Any thoughts on the timing and size of the next dilution? I assume they can currently fund these 12 patient trials. And if successful, they may see a very nice pop BEFORE any such offering. Thoughts appreciated. TIA.